Germline nuclear-predominant Pten murine model exhibits impaired social and perseverative behavior, microglial activation, and increased oxytocinergic activity.
Nick Sarn, Stetson Thacker, Hyunpil Lee and 1 others
PMID 34088332WHAT IT FOUND
In mice with a PTEN mutation linked to human autism, the mutated protein gathered in the cell nucleus.
These animals showed reduced sociability and repetitive behaviors, alongside brain immune cell activation and unexpectedly high oxytocin levels.
Key findings
01Mice with the nuclear-predominant Pten Y68H mutation exhibited decreased sociability and reduced preference for social novelty compared to controls.
02The mutant mice displayed increased repetitive behavior, evidenced by burying more marbles than wildtype littermates.
03Contrary to some autism models showing low oxytocin, these mice had significantly increased oxytocin expression in the hypothalamus.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study uses a mouse model, so findings cannot be directly applied to human patients without further translation. The Y68H mutation destabilizes the Pten protein, making it difficult to attribute observed effects solely to nuclear localization rather than reduced total Pten levels. The localization shift is relative, not absolute; significant amounts of Pten remained in the cytoplasm. Only heterozygous mice were studied because homozygous mutations are embryonic lethal, limiting the ability to study dose-dependent effects.
Declared interests
The study was funded by the Ambrose Monell Foundation. No other conflicts of interest were declared in the provided text.
The easy way to misread this
Do not interpret the increased oxytocin levels in these mice as evidence that oxytocin therapy would help this specific genetic subtype of autism. The paper notes this finding is paradoxical and may reflect compensatory mechanisms or receptor insensitivity, not a simple deficiency.